UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of:June 2017 (Report No. 3)
Commission file number:001- 38041
THERAPIX BIOSCIENCES LTD.
(Translation of registrant’s name into English)
5 Azrieli Center (Square Tower)
Tel-Aviv 6702501, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____
On June 28, 2017, each of Donald P. Dizon and David Silverman resigned from his position as a member of the Board of Directors (the “Board”) of Therapix Biosciences Ltd. (the “Company”). Mr. Dizon’s and Mr. Silverman’s resignations were not related to any disagreement with the Board on any matter relating to the operations, policies or practices of the Company.
On June 28, 2017, the Board appointed Eric So to the Board, effective immediately to fill the vacancy created by the resignation of Mr. Dizon. There are no arrangements or understandings between the Company and any other person pursuant to which Mr. So was selected as a director, nor are there any transactions between Mr. So and the Company in which he has a direct or indirect material interest that the Company is required to report pursuant to the rules and regulations of the Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Therapix Biosciences Ltd. (Registrant) | ||
By | /s/ Josh Blacher | |
Name: | Josh Blacher | |
Title: | Chief Financial Officer |
Date: June 29, 2017